Paper770206
Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids).
Sporn MB and 3 others. Fed Proc, 1976. Cited by 1,121 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Download JSON
Cite this record
ConductScience Library. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Papers, record 770206. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/770206
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids).
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinogens | Major topic |
| Neoplasms, Experimental | Major topic |
| Vitamin A | Major topic |
| Animals | |
| Cell Differentiation | |
| Epithelium | |
| Structure-Activity Relationship | |
| Vitamin A Deficiency |
Source PubMed
Cited by223
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,121 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,189,306 | Unveiling the anti-cancer properties of apigenin via targeting different molecular signatures: A Review. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42189306 | PubMed |
| 41,986,628 | Tumour promotion through the lens of evolution. | Nature | 2026 | https://conductscience.org/library/papers/41986628 | PubMed |
| 41,668,050 | Deciphering the cancer chemopreventive potential of phytochemicals: an integrative perspective on molecular targets and signaling networks. | Cancer Cell Int | 2026 | https://conductscience.org/library/papers/41668050 | PubMed |
| 41,009,705 | First Look at Chemopreventive Properties of Chlorella pyrenoidosa Water Extract in Human Endometrial Adenocarcinoma Cells-Preliminary In Vitro Study. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41009705 | PubMed |
| 40,988,712 | Sulforaphane as a potential therapeutic agent: a comprehensive analysis of clinical trials and mechanistic insights. | J Nutr Sci | 2025 | https://conductscience.org/library/papers/40988712 | PubMed |
| 40,867,250 | Stem Cell Origin of Cancer: Biological Principles and Clinical Strategies for Chemoprevention and Maintenance Therapy in Cancer Care. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40867250 | PubMed |
| 40,508,111 | The Hypoxia-Retinoid Axis in Idiopathic Pulmonary Fibrosis: Multifaceted Etiology and Therapeutic Potential. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40508111 | PubMed |
| 39,312,451 | Discovery of Natural Products for Cancer Prevention. | Cancer J | 2024 | https://conductscience.org/library/papers/39312451 | PubMed |
| 38,978,394 | Chemoprevention of Head and Neck Cancer: A Review of Current Approaches and Future Perspectives. | Cancer Prev Res (Phila) | 2024 | https://conductscience.org/library/papers/38978394 | PubMed |
| 38,954,771 | The Absorption, Storage, and Transport of Ocular Carotenoids and Retinoids. | Annu Rev Vis Sci | 2024 | https://conductscience.org/library/papers/38954771 | PubMed |
| 38,005,711 | Characterization of the Chemopreventive Properties of Cannabis sativa L. Inflorescences from Monoecious Cultivars Grown in Central Italy. | Plants (Basel) | 2023 | https://conductscience.org/library/papers/38005711 | PubMed |
| 38,004,456 | Potential Chemopreventive Effects of Dietary Combination of Phytochemicals against Cancer Development. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/38004456 | PubMed |
| 37,583,424 | Targeting nuclear hormone receptors for the prevention of breast cancer. | Front Med (Lausanne) | 2023 | https://conductscience.org/library/papers/37583424 | PubMed |
| 37,298,657 | Potential Chemopreventive Role of Pterostilbene in Its Modulation of the Apoptosis Pathway. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37298657 | PubMed |
| 37,237,998 | Pros and Cons of Dietary Vitamin A and Its Precursors in Poultry Health and Production: A Comprehensive Review. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/37237998 | PubMed |
| 36,532,545 | Omega 3 supplementation reduces C-reactive protein, prostaglandin E2 and the granulocyte/lymphocyte ratio in heavy smokers: An open-label randomized crossover trial. | Front Nutr | 2022 | https://conductscience.org/library/papers/36532545 | PubMed |
| 36,367,850 | The use of integrated text mining and protein-protein interaction approach to evaluate the effects of combined chemotherapeutic and chemopreventive agents in cancer therapy. | PLoS One | 2022 | https://conductscience.org/library/papers/36367850 | PubMed |
| 35,334,970 | Mechanisms of Feedback Regulation of Vitamin A Metabolism. | Nutrients | 2022 | https://conductscience.org/library/papers/35334970 | PubMed |
| 34,638,282 | Sulforaphane: A Broccoli Bioactive Phytocompound with Cancer Preventive Potential. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34638282 | PubMed |
| 34,502,529 | Novel Nitrogen-Based Chalcone Analogs Provoke Substantial Apoptosis in HER2-Positive Human Breast Cancer Cells via JNK and ERK1/ERK2 Signaling Pathways. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34502529 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/770206
GET https://conductscience.org/api/papers/v1/770206/cited_by?page=2